(±)-13-Azaprostanoic acid is a synthetic compound that belongs to the class of prostanoids, which are biologically active lipids derived from arachidonic acid. This compound features a unique azole ring structure, which contributes to its pharmacological properties. It is characterized by its ability to interact with prostaglandin receptors, influencing various physiological processes such as inflammation, pain modulation, and vascular function. The presence of the azole moiety in its structure enhances its stability and bioactivity compared to traditional prostaglandins. (±)-13-Azaprostanoic acid is typically studied for its potential therapeutic applications, including its role in cardiovascular health and as an anti-inflammatory agent. Its stereochemistry, indicated by the (±) notation, suggests that it exists as a racemic mixture of enantiomers, which may exhibit different biological activities. As with many prostanoid derivatives, the compound's solubility, stability, and interaction with biological systems are critical factors in its development for clinical use.

(+-)-13-azaprostanoic acid

71629-07-7: (±)-13-Azaprostanoic acid is a synthetic compound that belongs to the class of prostanoids, which are biologically active lipids derived from arachidonic acid. This compound features a unique azole ring structure, which contributes to its pharmacological properties. It is characterized by its ability to interact with prostaglandin receptors, influencing various physiological processes such as inflammation, pain modulation, and vascular function. The presence of the azole moiety in its structure enhances its stability and bioactivity compared to traditional prostaglandins. (±)-13-Azaprostanoic acid is typically studied for its potential therapeutic applications, including its role in cardiovascular health and as an anti-inflammatory agent. Its stereochemistry, indicated by the (±) notation, suggests that it exists as a racemic mixture of enantiomers, which may exhibit different biological activities. As with many prostanoid derivatives, the compound's solubility, stability, and interaction with biological systems are critical factors in its development for clinical use.

CAS 71629-07-7

(+-)-13-azaprostanoic acid